ERIS
Invest with MTF
Invest Now
Invest in Eris Lifesciences with 3.35X leverage
Performance
- Low
- ₹1,467
- High
- ₹1,507
- 52 Week Low
- ₹1,097
- 52 Week High
- ₹1,910
- Open Price₹1,507
- Previous Close₹1,494
- Volume48,910
- 50 DMA₹1,564.90
- 100 DMA₹1,588.46
- 200 DMA₹1,558.28
Investment Returns
- Over 1 Month -6.05%
- Over 3 Month -8.26%
- Over 6 Month -13.61%
- Over 1 Year + 18.31%
Smart Investing Starts Here Start SIP with Eris Lifesciences for Steady Growth!
Eris Lifesciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 48.4
- PEG Ratio
- 2.5
- Market Cap Cr
- 20,121
- P/B Ratio
- 6.5
- Average True Range
- 41.12
- EPS
- 30.52
- Dividend Yield
- 0.5
- MACD Signal
- -17.22
- RSI
- 35.76
- MFI
- 28.22
Eris Lifesciences Financials
Eris Lifesciences Technicals
EMA & SMA
Current Price
₹1,477.10
-17.2
(-1.15%)
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹1,533.20
- 50 Day
- ₹1,564.90
- 100 Day
- ₹1,588.46
- 200 Day
- ₹1,558.28
Resistance and Support
1483.57
- R3 1,540.03
- R2 1,523.37
- R1 1,500.23
- S1 1,460.43
- S2 1,443.77
- S3 1,420.63
Eris Lifesciences Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-24 | Preferential issue of shares | Inter-alia, To consider the protposal of issuance ofequity shares of the Company by way of a preferential issue for consideration other than cash.. per share(601%)Interim Dividend |
| 2025-11-12 | Quarterly Results | |
| 2025-08-05 | Quarterly Results | |
| 2025-05-19 | Audited Results | |
| 2025-02-07 | Interim Dividend |
Eris Lifesciences F&O
About Eris Lifesciences
- NSE Symbol
- ERIS
- BSE Symbol
- 540596
- Chairperson & Managing Director
- Mr. Amit Bakshi
- ISIN
- INE406M01024
Similar Stocks to Eris Lifesciences
Eris Lifesciences FAQs
Eris Lifesciences share price is ₹1,477 As on 14 January, 2026 | 07:24
The Market Cap of Eris Lifesciences is ₹20120.6 Cr As on 14 January, 2026 | 07:24
The P/E ratio of Eris Lifesciences is 48.4 As on 14 January, 2026 | 07:24
The PB ratio of Eris Lifesciences is 6.5 As on 14 January, 2026 | 07:24
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.